Literature DB >> 17643263

Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.

Corinne Pellieux1, Christophe Montessuit, Irène Papageorgiou, René Lerch.   

Abstract

Inactivation of peroxisome proliferator-activated receptor (PPARs) isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes. PPARs are ligand-activated transcription factors that modulate the transcriptional regulation of fatty acid metabolism and the hypertrophic response in neonatal cardiac myocytes. The purpose of this study was to determine the role of PPAR isoforms in the morphologic and metabolic phenotype transformation of adult cardiac myocytes in culture, which, in medium containing 20% fetal calf serum, undergo hypertrophy-like cell growth associated with downregulation of regulatory proteins of fatty acid metabolism. Expression and DNA-binding activity of PPARalpha, PPARbeta/delta, and PPARgamma rapidly decreased after cell isolation and remained persistently reduced during the 14-day culture period. Cells progressively increased in size and developed both re-expression of atrial natriuretic factor and downregulation of regulatory proteins of fatty acid metabolism. Supplementation of the medium with fatty acid (oleate 0.25 mM/palmitate 0.25 mM) prevented inactivation of PPARs and downregulation of metabolic genes. Furthermore, cell size and markers of hypertrophy were markedly reduced. Selective activation of either PPARalpha or PPARbeta/delta completely restored expression of regulatory genes of fatty acid metabolism but did not influence cardiac myocyte size and markers of hypertrophy. Conversely, activation of PPARgamma prevented cardiomyocyte hypertrophy but had no effect on fatty acid metabolism. The results indicate that PPAR activity markedly influences hypertrophic transformation of adult rat cardiac myocytes. Inactivation of PPARalpha and PPARbeta/delta accounts for downregulation of the fatty acid oxidation pathway, whereas inactivation of PPARgamma enables development of hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643263     DOI: 10.1007/s00424-007-0297-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  46 in total

1.  Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation.

Authors:  Nathalie Rosenblatt-Velin; René Lerch; Irène Papageorgiou; Christophe Montessuit
Journal:  FASEB J       Date:  2004-03-19       Impact factor: 5.191

2.  Retinoic acids increase expression of GLUT4 in dedifferentiated and hypertrophied cardiac myocytes.

Authors:  Christophe Montessuit; Irène Papageorgiou; Lis Campos; René Lerch
Journal:  Basic Res Cardiol       Date:  2005-11-10       Impact factor: 17.165

3.  Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.

Authors:  Sheng Zhong Duan; Christine Y Ivashchenko; Mark W Russell; David S Milstone; Richard M Mortensen
Journal:  Circ Res       Date:  2005-07-28       Impact factor: 17.367

4.  Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.

Authors:  A Remondino; N Rosenblatt-Velin; C Montessuit; I Tardy; I Papageorgiou; P A Dorsaz; M Jorge-Costa; R Lerch
Journal:  J Mol Cell Cardiol       Date:  2000-11       Impact factor: 5.000

5.  Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.

Authors:  H Takano; T Nagai; M Asakawa; T Toyozaki; T Oka; I Komuro; T Saito; Y Masuda
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

Review 6.  Controversies in ventricular remodelling.

Authors:  Lionel H Opie; Patrick J Commerford; Bernard J Gersh; Marc A Pfeffer
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

7.  Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.

Authors:  K Yamamoto; R Ohki; R T Lee; U Ikeda; K Shimada
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

8.  Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

Authors:  M N Sack; T A Rader; S Park; J Bastin; S A McCune; D P Kelly
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

9.  Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes.

Authors:  M Y Donath; J Zapf; M Eppenberger-Eberhardt; E R Froesch; H M Eppenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

Review 10.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  2 in total

1.  PPARgamma2 expression in growth plate chondrocytes is regulated by p38 and GSK-3.

Authors:  Lee-Anne Stanton; Jennifer Ruizhe Li; Frank Beier
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

2.  Valsartan inhibits RhoA-ROCK2-MYL pathway in rat model of alcoholic cardiomyopathy.

Authors:  Luyifei Li; Ling Jing; Jiyi Zhao; Jiachen Lv; Wen Yang; Weimin Li; Lijun Zhou
Journal:  Exp Ther Med       Date:  2019-10-07       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.